[Vasomotor properties of mercaptoethylguanidine (MEG) in the rat].
D000313:Adrenal Medulla / Q000032:analysis; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D003538:Cystamine / Q000494:pharmacology; D003543:Cysteamine / Q000494:pharmacology; D004837:Epinephrine / Q000032:analysis; D006146:Guanidines / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006636:Histamine Release; D009638:Norepinephrine / Q000032:analysis; D051381:Rats; D013438:Sulfhydryl Compounds / Q000494:pharmacology*; D000338:beta-Aminoethyl Isothiourea
D006146:Guanidines; D006634:Histamine H1 Antagonists; D013438:Sulfhydryl Compounds; D000338:beta-Aminoethyl Isothiourea; D003543:Cysteamine; D003538:Cystamine; D009638:Norepinephrine; D004837:Epinephrine
Propriétés vasomotrices de la 2-mercaptoéthylguanidine (MEG) chez le rat.